title: [The mirages of the new oral anticoagulants].
authors.forename: A S
authors.initials: AS
authors.lastname: Larock
authors.forename: F
authors.initials: F
authors.lastname: Mullier
authors.forename: P
authors.initials: P
authors.lastname: Laloux
authors.forename: J
authors.initials: J
authors.lastname: Douxfis
authors.forename: J M
authors.initials: JM
authors.lastname: Dogné
authors.forename: A
authors.initials: A
authors.lastname: Spinewine
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000009:adverse effects* / Q000493:pharmacokinetics / Q000627:therapeutic use*; D001281:Atrial Fibrillation / Q000188:drug therapy; D001562:Benzimidazoles / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D000069604:Dabigatran; D004347:Drug Interactions; D006801:Humans; D008297:Male; D010291:Paresis / Q000209:etiology; D010607:Pharmacy Service, Hospital; D011725:Pyridines / Q000009:adverse effects / Q000493:pharmacokinetics / Q000627:therapeutic use; D020521:Stroke / Q000188:drug therapy
chemical_list: D000925:Anticoagulants; D001562:Benzimidazoles; D011725:Pyridines; D000069604:Dabigatran